Neurocrine Biosciences Inc. (NASDAQ: NBIX) completed its acquisition of Soleno Therapeutics Inc., adding VYKAT XR to its rare disease portfolio ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions